WEBVTT

1
00:00:11.560 --> 00:00:14.880
<v Speaker 1>Hello, this is the Itchy and Bitchy Podcast because being

2
00:00:15.080 --> 00:00:19.640
<v Speaker 1>itchy is bitchy and our medical system sucks. I'm doctor

3
00:00:19.719 --> 00:00:23.079
<v Speaker 1>Keith Milica, a vetnary, allergist and dermatologist.

4
00:00:22.519 --> 00:00:25.399
<v Speaker 2>And I'm Stephen Miller, a doctor of nursing practice and

5
00:00:25.480 --> 00:00:27.039
<v Speaker 2>a Q Care nurse practitioner.

6
00:00:27.399 --> 00:00:31.519
<v Speaker 1>Send us your questions at ask at itch not dot com.

7
00:00:32.200 --> 00:00:34.640
<v Speaker 1>We love you, but we're not your doctors. The information

8
00:00:34.759 --> 00:00:38.520
<v Speaker 1>we discuss is not direct medical advice. Please talk to

9
00:00:38.560 --> 00:00:42.520
<v Speaker 1>your provider who is the expert on your care. The

10
00:00:42.560 --> 00:00:46.240
<v Speaker 1>Itchy and BITCHI podcast is sponsored by doc Itchy Medical

11
00:00:46.280 --> 00:00:49.799
<v Speaker 1>Pets supplements designed to optimize your pets health with the

12
00:00:49.880 --> 00:00:54.920
<v Speaker 1>latest veterinary medical research. Visit docichi dot com or find

13
00:00:55.000 --> 00:00:58.600
<v Speaker 1>us on Amazon and please click that follow button and

14
00:00:58.679 --> 00:01:06.359
<v Speaker 1>send us a question at a at itchno dot com. Thanks, hello,

15
00:01:06.959 --> 00:01:08.640
<v Speaker 1>doctor Miller, how's it going.

16
00:01:08.879 --> 00:01:12.599
<v Speaker 2>Hi? Welcome to all of our listeners. I'm so glad

17
00:01:12.599 --> 00:01:13.439
<v Speaker 2>we're back together.

18
00:01:13.920 --> 00:01:17.239
<v Speaker 1>Yes, and we're now posting on Mondays, so look for

19
00:01:17.280 --> 00:01:19.159
<v Speaker 1>the uploads on Monday morning.

20
00:01:19.079 --> 00:01:21.840
<v Speaker 2>And we hope that you will go on our Facebook

21
00:01:21.920 --> 00:01:25.239
<v Speaker 2>site which I and B Podcast.

22
00:01:24.840 --> 00:01:27.959
<v Speaker 1>And send us a question that ask at itch not

23
00:01:28.159 --> 00:01:30.200
<v Speaker 1>dot com Okay, so.

24
00:01:30.560 --> 00:01:31.200
<v Speaker 3>Are you ready?

25
00:01:31.359 --> 00:01:33.359
<v Speaker 1>Yeah, Okay, this is going to be a whirlwind because

26
00:01:33.400 --> 00:01:37.439
<v Speaker 1>this is the craziest, most amazing thing I can think of.

27
00:01:38.239 --> 00:01:41.920
<v Speaker 1>There are three major events that I know of in

28
00:01:41.959 --> 00:01:46.480
<v Speaker 1>my lifetime sort of in my lifetime that absolutely revolutionized

29
00:01:46.760 --> 00:01:48.359
<v Speaker 1>medicine as we know.

30
00:01:48.439 --> 00:01:50.840
<v Speaker 3>It just totally changed the human species.

31
00:01:51.120 --> 00:01:53.480
<v Speaker 2>Detail it soundsl.

32
00:01:53.079 --> 00:01:56.799
<v Speaker 1>So the first is antabotics. What have antibotics done for humans?

33
00:01:56.840 --> 00:02:06.079
<v Speaker 1>Doctor Miller cured like death, repentuated eighty percent society, So antibotics.

34
00:02:06.239 --> 00:02:11.199
<v Speaker 1>The second most tragic, crazy thing that happened total misadventure

35
00:02:11.360 --> 00:02:14.080
<v Speaker 1>is the lidamide. So this was in the nineteen fifties

36
00:02:14.080 --> 00:02:17.719
<v Speaker 1>and sixties during the valium culture. Mother's Little Helper, make

37
00:02:17.800 --> 00:02:22.719
<v Speaker 1>you happy, and so thalidamide was an anti vomit morning

38
00:02:22.759 --> 00:02:27.599
<v Speaker 1>sickness drug and it turned out to cause horrible birth defects.

39
00:02:27.960 --> 00:02:31.319
<v Speaker 1>Luckily our FDA, which some people don't like very much,

40
00:02:31.360 --> 00:02:34.120
<v Speaker 1>but they did not approve in the United States, so

41
00:02:34.560 --> 00:02:38.639
<v Speaker 1>a lot of American babies were spared from the limb deformities.

42
00:02:39.000 --> 00:02:42.240
<v Speaker 1>But thalidamide was this amazing feel good drug in the

43
00:02:42.240 --> 00:02:46.680
<v Speaker 1>fifties and sixties for pregnant women, but caused horrible birth

44
00:02:46.719 --> 00:02:51.599
<v Speaker 1>defects and a whole generation of birth defects. So horrible,

45
00:02:51.639 --> 00:02:57.240
<v Speaker 1>horrible misadventure. But what's crazy amazing, like the best of

46
00:02:57.319 --> 00:03:01.080
<v Speaker 1>times the worst of times, is this gel one revolution.

47
00:03:01.759 --> 00:03:05.719
<v Speaker 1>And I have not seen any other drug or treatment

48
00:03:05.840 --> 00:03:10.000
<v Speaker 1>that falls into this kind of crazy madness of exploration

49
00:03:10.879 --> 00:03:13.639
<v Speaker 1>and benefits. And so we're going to talk about GLP

50
00:03:13.759 --> 00:03:18.719
<v Speaker 1>ones again. This is an updated version. Karen Nicol did

51
00:03:18.759 --> 00:03:22.319
<v Speaker 1>a really good episode previously, check that out if you

52
00:03:22.360 --> 00:03:27.719
<v Speaker 1>would like. But things have changed in months, definitely within

53
00:03:27.719 --> 00:03:31.159
<v Speaker 1>the last year. But every week there's new and new things.

54
00:03:31.240 --> 00:03:33.680
<v Speaker 1>So we're going to divide this episode into sort of

55
00:03:33.680 --> 00:03:37.560
<v Speaker 1>an introduction and then what GLP ones are actually approved

56
00:03:37.680 --> 00:03:40.520
<v Speaker 1>for and how that sort of got started, and then

57
00:03:40.520 --> 00:03:42.400
<v Speaker 1>we're going to take a break and come back and

58
00:03:42.439 --> 00:03:46.080
<v Speaker 1>talk about all of the possibilities and the proposed mechanisms.

59
00:03:46.400 --> 00:03:48.879
<v Speaker 1>A lot of them are thought of and sort of

60
00:03:49.240 --> 00:03:53.439
<v Speaker 1>hinted at by response to therapy, but not documented in

61
00:03:53.560 --> 00:03:58.000
<v Speaker 1>really good clinical statistical trials. And then we're going to

62
00:03:58.319 --> 00:04:01.240
<v Speaker 1>have a last segment of the possible side effects, which

63
00:04:01.360 --> 00:04:05.280
<v Speaker 1>are kind of interesting when you start thinking about mechanisms

64
00:04:05.639 --> 00:04:07.759
<v Speaker 1>of how the GLP actually works.

65
00:04:07.960 --> 00:04:11.199
<v Speaker 2>And for our listeners, that don't know. What GLP one

66
00:04:11.400 --> 00:04:17.360
<v Speaker 2>receptor agonists are is glucagon like peptide receptor agonists, and

67
00:04:17.439 --> 00:04:23.160
<v Speaker 2>so these offer all kinds of benefits for metabolic, cardiovascular, renal,

68
00:04:23.240 --> 00:04:26.040
<v Speaker 2>and weight related benefits. So we'll we'll dive in.

69
00:04:26.279 --> 00:04:29.920
<v Speaker 1>Yeah, so glucagon is produced in the liver, and agonist

70
00:04:30.040 --> 00:04:33.040
<v Speaker 1>means that we're going to stimulate the receptors and so

71
00:04:33.240 --> 00:04:36.279
<v Speaker 1>molecularly that's how these things work.

72
00:04:36.720 --> 00:04:38.399
<v Speaker 3>And so we started off.

73
00:04:38.759 --> 00:04:41.040
<v Speaker 1>Do you remember when they first got approved three years

74
00:04:41.040 --> 00:04:42.360
<v Speaker 1>ago maybe four?

75
00:04:42.839 --> 00:04:44.000
<v Speaker 3>Yeah, so so.

76
00:04:44.079 --> 00:04:46.319
<v Speaker 1>Not that long ago in the grand scheme of things,

77
00:04:46.600 --> 00:04:49.319
<v Speaker 1>and they were first approved. You remember the first drug

78
00:04:49.360 --> 00:04:50.000
<v Speaker 1>that was approved.

79
00:04:50.199 --> 00:04:53.319
<v Speaker 2>The first one was sex Sinda and.

80
00:04:53.319 --> 00:04:57.360
<v Speaker 3>It was approved for weight loss. Weight lossbetes that.

81
00:04:57.680 --> 00:04:59.720
<v Speaker 2>They are a glue tide. It was indicated for what

82
00:04:59.759 --> 00:05:05.680
<v Speaker 2>loss Victosa, which was the branded other version. With all

83
00:05:05.720 --> 00:05:08.720
<v Speaker 2>of these classes, they get branded in different ways, and

84
00:05:08.759 --> 00:05:11.480
<v Speaker 2>so the branding of Victosa was to decrease cardio event

85
00:05:12.079 --> 00:05:18.639
<v Speaker 2>cardiovascular event reduction in patients with diabetes and established cardiovascular disease.

86
00:05:18.759 --> 00:05:22.800
<v Speaker 1>So very specific prescribing guidelines, and so I would bet

87
00:05:22.839 --> 00:05:24.920
<v Speaker 1>that when it first came out, you didn't really prescribe

88
00:05:24.920 --> 00:05:27.079
<v Speaker 1>it to a huge number of patients.

89
00:05:27.040 --> 00:05:31.399
<v Speaker 2>On the cardiology side. We didn't dive in initially.

90
00:05:31.519 --> 00:05:34.879
<v Speaker 1>That's accurate, okay, So and this is just kind of

91
00:05:34.920 --> 00:05:37.000
<v Speaker 1>back up a step, and then we're going to take

92
00:05:37.000 --> 00:05:39.759
<v Speaker 1>a short break and come back with more detail. But

93
00:05:39.920 --> 00:05:42.800
<v Speaker 1>to back up a step, this is one of the peptides.

94
00:05:42.839 --> 00:05:46.560
<v Speaker 1>And peptides are all trendy now, but you need to

95
00:05:46.639 --> 00:05:49.680
<v Speaker 1>kind of understand what peptides are. They're simply proteins that

96
00:05:49.720 --> 00:05:52.959
<v Speaker 1>are found in the human body and interesting like other

97
00:05:53.120 --> 00:05:57.560
<v Speaker 1>drugs that are patented and drug companies like Pfizer or

98
00:05:57.639 --> 00:06:01.639
<v Speaker 1>Eli Lilly can have a patent on it. The Supreme

99
00:06:01.680 --> 00:06:05.199
<v Speaker 1>Court decided that these peptides are human proteins because they're

100
00:06:05.279 --> 00:06:10.279
<v Speaker 1>part of the human normal anatomy system, that they're not patentable.

101
00:06:10.399 --> 00:06:14.279
<v Speaker 1>So these peptides are very specific and they have pros

102
00:06:14.319 --> 00:06:17.600
<v Speaker 1>and cons They have benefits and side effects depending on

103
00:06:17.680 --> 00:06:20.439
<v Speaker 1>exactly what the peptide is and what it does. So

104
00:06:20.519 --> 00:06:22.399
<v Speaker 1>we're going to take a short break here and then

105
00:06:22.399 --> 00:06:26.439
<v Speaker 1>we're going to come back and talk about the proposed

106
00:06:26.720 --> 00:06:32.560
<v Speaker 1>and approved guidelines and treatment possibilities for these glp ones.

107
00:06:32.600 --> 00:06:33.240
<v Speaker 3>Stick with us.

108
00:06:33.519 --> 00:06:37.759
<v Speaker 1>It gets really interesting and really crazy from here. It's

109
00:06:37.759 --> 00:06:41.040
<v Speaker 1>magical medicine moments. So hang with us.

110
00:06:52.240 --> 00:06:55.360
<v Speaker 3>All right, we're back. I hope he stayed with us.

111
00:06:55.759 --> 00:06:57.439
<v Speaker 1>So now we're going to talk about all of the

112
00:06:57.480 --> 00:07:03.079
<v Speaker 1>different proposed treatments and treatments for these GLP ones and

113
00:07:03.720 --> 00:07:07.120
<v Speaker 1>it gets it gets really interesting. So just as crazy

114
00:07:07.560 --> 00:07:11.839
<v Speaker 1>as antibotics and pholidamide, where these GLP one started off

115
00:07:11.879 --> 00:07:15.319
<v Speaker 1>with this little bitty niche kind of treatment protocol and

116
00:07:15.399 --> 00:07:19.079
<v Speaker 1>now it is just crazy what they're showing to have

117
00:07:19.120 --> 00:07:24.839
<v Speaker 1>benefits for. So from the data side of things, Stephen,

118
00:07:24.920 --> 00:07:27.600
<v Speaker 1>what what are they actually used for and prescribed for?

119
00:07:27.839 --> 00:07:28.279
<v Speaker 3>Right now?

120
00:07:28.519 --> 00:07:31.160
<v Speaker 2>Yeah, so follow me into the weeds a moment.

121
00:07:31.600 --> 00:07:33.959
<v Speaker 3>Yes, I like weeds. Yeah, data is good, give me

122
00:07:34.000 --> 00:07:34.560
<v Speaker 3>a good action.

123
00:07:34.600 --> 00:07:38.040
<v Speaker 2>And so initially we talked about sex and and nick tosa,

124
00:07:38.120 --> 00:07:42.240
<v Speaker 2>and then the next generation was seema glue tide, which

125
00:07:43.360 --> 00:07:49.399
<v Speaker 2>was ozimpic, and then Rightbelsa's and we go by and

126
00:07:49.439 --> 00:07:53.879
<v Speaker 2>they're all it's interesting how as they've been branded, they

127
00:07:54.120 --> 00:07:58.480
<v Speaker 2>the branding has has been approved for certain different indications.

128
00:07:58.920 --> 00:08:01.959
<v Speaker 2>And so this is why people will meet barriers at

129
00:08:01.959 --> 00:08:04.920
<v Speaker 2>the pharmacy counter if the drugs not written under the

130
00:08:05.040 --> 00:08:09.240
<v Speaker 2>certain indication that it's approved for. And so for example,

131
00:08:09.279 --> 00:08:13.759
<v Speaker 2>we go V is for weight management and obesity with

132
00:08:13.879 --> 00:08:18.279
<v Speaker 2>weight related comorbidities, which is kind of a broad label and.

133
00:08:18.199 --> 00:08:22.240
<v Speaker 1>That could be anything from diabetes, pre diabetes, even cancer

134
00:08:22.360 --> 00:08:23.519
<v Speaker 1>is related to abusie.

135
00:08:23.680 --> 00:08:28.800
<v Speaker 2>It is also indicated for cardiovascular event reduction and obese

136
00:08:28.839 --> 00:08:34.320
<v Speaker 2>patients with established cardiovascular disease, so anybody with atherosclerosis. And

137
00:08:34.360 --> 00:08:39.320
<v Speaker 2>then it is also indicated for metabolic dysfunction with fatty

138
00:08:39.360 --> 00:08:43.720
<v Speaker 2>liver disease, specifically looking more into fibrosis of the liver.

139
00:08:43.879 --> 00:08:47.879
<v Speaker 1>So glucagon is liver produced and so that's where this

140
00:08:48.000 --> 00:08:49.759
<v Speaker 1>whole mechanism kind of.

141
00:08:51.279 --> 00:08:54.519
<v Speaker 3>Resides in the body. So how do they so all

142
00:08:54.559 --> 00:08:57.720
<v Speaker 3>of these peptides are similar in cross reaction.

143
00:08:57.879 --> 00:09:02.200
<v Speaker 2>Yeah, so it wasn't done because they have to give indications.

144
00:09:01.320 --> 00:09:05.080
<v Speaker 1>Right, but do the pharmacist and the providers if so,

145
00:09:05.159 --> 00:09:08.159
<v Speaker 1>if they have a lot of overlap, but are they prescribing?

146
00:09:08.919 --> 00:09:12.440
<v Speaker 1>You want you want treatment A, and so you do

147
00:09:12.600 --> 00:09:14.759
<v Speaker 1>drug A, and you want treatment B, so you do

148
00:09:14.879 --> 00:09:17.320
<v Speaker 1>drug B even though both drugs will do A.

149
00:09:17.559 --> 00:09:18.120
<v Speaker 3>That's great.

150
00:09:18.480 --> 00:09:24.080
<v Speaker 2>And so in the clinical setting, if you are prescribing,

151
00:09:24.519 --> 00:09:30.320
<v Speaker 2>say for example, you're prescribing zep bound, which is tears

152
00:09:30.360 --> 00:09:34.279
<v Speaker 2>zeppatide and it's approved for chronic weight management and obstructive

153
00:09:34.360 --> 00:09:39.399
<v Speaker 2>sleep apnea. And if the patient doesn't have those disease processes,

154
00:09:40.120 --> 00:09:44.480
<v Speaker 2>but yet they may have cardiovascular disease, then they would

155
00:09:44.480 --> 00:09:47.879
<v Speaker 2>be covered for we go Vy, which has the cardiovascular indication.

156
00:09:48.000 --> 00:09:50.720
<v Speaker 1>So that becomes an insurance paperwork kind of thing. But

157
00:09:50.919 --> 00:09:53.480
<v Speaker 1>as far as the drug is actually the mechanism of action,

158
00:09:53.600 --> 00:09:56.639
<v Speaker 1>does it really matter which one tick and then some

159
00:09:56.759 --> 00:09:59.480
<v Speaker 1>maybe once you're next summer, once a day. They now

160
00:09:59.519 --> 00:10:02.720
<v Speaker 1>have oral drugs because it's much cheaper and easier to administer,

161
00:10:03.000 --> 00:10:05.759
<v Speaker 1>so their injecting devices are actually quite expensive.

162
00:10:06.000 --> 00:10:09.159
<v Speaker 2>Yeah, so there's oral we go Vi, which is now available.

163
00:10:09.200 --> 00:10:15.039
<v Speaker 2>There's Rybelsis, which is semaglutide as well, and it has

164
00:10:15.080 --> 00:10:18.759
<v Speaker 2>the indications for diabetes cardiovasco or men reduction in patients

165
00:10:18.759 --> 00:10:20.360
<v Speaker 2>with type two diabetes melitis.

166
00:10:20.399 --> 00:10:22.799
<v Speaker 1>So we're kind of in this situation where we have

167
00:10:22.879 --> 00:10:27.039
<v Speaker 1>lots of different drugs and the paperwork kind of regulates

168
00:10:27.080 --> 00:10:31.440
<v Speaker 1>which drug gets which diagnosis and which treatment, but in reality,

169
00:10:31.679 --> 00:10:34.559
<v Speaker 1>all of the drugs kind of do similar things and

170
00:10:34.600 --> 00:10:37.720
<v Speaker 1>they have an expanding list of benefits.

171
00:10:37.879 --> 00:10:41.360
<v Speaker 2>Yeah, so patients just need to discuss this with their

172
00:10:41.519 --> 00:10:45.519
<v Speaker 2>prescribing provider to make sure that whatever drug is written

173
00:10:45.799 --> 00:10:49.120
<v Speaker 2>is written under the labeling that's appropriate.

174
00:10:49.679 --> 00:10:51.639
<v Speaker 1>Okay, otherwise you're going to get pushed back from your

175
00:10:51.639 --> 00:10:52.440
<v Speaker 1>insurance company.

176
00:10:52.480 --> 00:10:54.320
<v Speaker 3>That's right. So I'm going to.

177
00:10:54.240 --> 00:10:58.600
<v Speaker 1>Read a list of all of the proposed theoretical benefits

178
00:10:58.639 --> 00:11:01.519
<v Speaker 1>that may or may not have been proven with really

179
00:11:01.559 --> 00:11:05.799
<v Speaker 1>good statistical studies based on tens of thousands of people.

180
00:11:06.080 --> 00:11:09.200
<v Speaker 1>But I want you first to tell me what the

181
00:11:09.360 --> 00:11:11.559
<v Speaker 1>actual approved indications are.

182
00:11:11.840 --> 00:11:17.639
<v Speaker 2>So really you want to break the benefits down into

183
00:11:18.399 --> 00:11:22.639
<v Speaker 2>three major categories, or four major categories. One is glycemic.

184
00:11:22.000 --> 00:11:24.440
<v Speaker 3>Control, which is sugar dibe.

185
00:11:24.240 --> 00:11:28.159
<v Speaker 2>Like glucose, and the other is weight loss, The other

186
00:11:28.360 --> 00:11:35.279
<v Speaker 2>is cardiovascular benefits, and then of course renal protection, and

187
00:11:35.320 --> 00:11:39.559
<v Speaker 2>then I left off one, which is the fatty liver indication.

188
00:11:40.000 --> 00:11:43.679
<v Speaker 1>Okay, So those are the indications. But what gets really

189
00:11:43.759 --> 00:11:47.120
<v Speaker 1>crazy and why this drug is so amazing is that

190
00:11:47.159 --> 00:11:51.759
<v Speaker 1>it's one of the moments in medicine where the expected

191
00:11:51.840 --> 00:11:57.039
<v Speaker 1>benefits were fairly narrow and limited, and then what the

192
00:11:57.120 --> 00:12:02.799
<v Speaker 1>patients are actually experiencing has just exponentially exploded. So under

193
00:12:02.840 --> 00:12:06.559
<v Speaker 1>weight loss, for instance, your joints get better. Under weight loss,

194
00:12:06.600 --> 00:12:12.000
<v Speaker 1>your libido gets better. So it's just this crazy exponential,

195
00:12:12.559 --> 00:12:17.799
<v Speaker 1>expansive list of benefits that these drugs have, even into depression, anxiety,

196
00:12:18.039 --> 00:12:18.720
<v Speaker 1>drug addiction.

197
00:12:18.960 --> 00:12:22.200
<v Speaker 2>So on my end, I really pitt because I'm work

198
00:12:22.519 --> 00:12:28.039
<v Speaker 2>in cardiology. You look at just so, cardiovascular death as

199
00:12:28.080 --> 00:12:31.159
<v Speaker 2>the number one leading cause of death in the United States, right,

200
00:12:31.519 --> 00:12:36.120
<v Speaker 2>So they did this meta analysis, which was ten clinical

201
00:12:36.159 --> 00:12:39.759
<v Speaker 2>trials looking at seventy three hundred and fifty one patients.

202
00:12:39.759 --> 00:12:43.200
<v Speaker 2>That's a huge number of patients. And so major adverse

203
00:12:43.240 --> 00:12:47.279
<v Speaker 2>cardiovascular events such as stroke, cardiovascular death, and non fatal

204
00:12:47.360 --> 00:12:52.519
<v Speaker 2>am I were reduced by fourteen percent, heart failure hospitalizations

205
00:12:52.559 --> 00:12:56.679
<v Speaker 2>were reduced by fourteen percent, and then all cause mortality

206
00:12:56.720 --> 00:12:59.960
<v Speaker 2>for dying from anything was reduced by about twelve percent.

207
00:13:00.200 --> 00:13:04.600
<v Speaker 2>So just looking at the one indicated group, the major

208
00:13:04.960 --> 00:13:08.879
<v Speaker 2>reductions in depth are impressive with this drug class.

209
00:13:09.000 --> 00:13:12.200
<v Speaker 1>Yeah, and anything above ten percent is really pretty significant.

210
00:13:12.240 --> 00:13:14.120
<v Speaker 1>So Okay, we're going to take a short break and

211
00:13:14.120 --> 00:13:16.279
<v Speaker 1>then we're going to come back and talk about the

212
00:13:16.480 --> 00:13:19.480
<v Speaker 1>other benefits. So if they look at these studies and

213
00:13:19.480 --> 00:13:21.320
<v Speaker 1>they're more and more of them, So we have now

214
00:13:21.440 --> 00:13:25.320
<v Speaker 1>hundreds of thousands of patients globally that are on these medications,

215
00:13:25.759 --> 00:13:27.879
<v Speaker 1>and what they do is they say, well, what else

216
00:13:27.960 --> 00:13:31.399
<v Speaker 1>is happening in these groups of patients? So anything above

217
00:13:31.440 --> 00:13:33.919
<v Speaker 1>ten percent is really impressive. But when we come back,

218
00:13:33.960 --> 00:13:37.440
<v Speaker 1>we're going to talk about some of these unexpected things,

219
00:13:37.480 --> 00:13:40.440
<v Speaker 1>like a thirty percent reduction in cancer risk.

220
00:13:40.519 --> 00:13:42.759
<v Speaker 2>And I think it's really really important for our listeners

221
00:13:42.799 --> 00:13:47.279
<v Speaker 2>to understand that when we're looking at some of these benefits,

222
00:13:47.600 --> 00:13:50.720
<v Speaker 2>that most of those things are coming out of subgroup

223
00:13:50.759 --> 00:13:53.039
<v Speaker 2>analysis from these studies. So it may not be the

224
00:13:53.080 --> 00:13:56.879
<v Speaker 2>indication for the drug, but certainly benefit was seen and.

225
00:13:56.799 --> 00:13:59.240
<v Speaker 1>More evidence is needed before it's a proven So we

226
00:13:59.279 --> 00:14:02.279
<v Speaker 1>have correlation but not causation yet. Okay, we're going to

227
00:14:02.320 --> 00:14:03.600
<v Speaker 1>take a break and then we're going to come back

228
00:14:03.639 --> 00:14:07.799
<v Speaker 1>and talk about these kind of amazingly weird, crazy things

229
00:14:07.799 --> 00:14:11.879
<v Speaker 1>that this drug therapies can do. Okay, hang tight and

230
00:14:12.000 --> 00:14:27.519
<v Speaker 1>join us on the other side. Hey, I hope you

231
00:14:27.559 --> 00:14:28.399
<v Speaker 1>made it back with us.

232
00:14:28.840 --> 00:14:30.159
<v Speaker 3>So what we're going to do is I'm going.

233
00:14:30.080 --> 00:14:32.639
<v Speaker 1>To read a list of all of the proposed benefits

234
00:14:32.679 --> 00:14:35.360
<v Speaker 1>and doctor Miller here is going to chime in with

235
00:14:35.399 --> 00:14:40.440
<v Speaker 1>some data if he has any kind of opinion about it.

236
00:14:40.480 --> 00:14:43.399
<v Speaker 1>So I looked up on Claude. Actually is what I've

237
00:14:43.399 --> 00:14:46.759
<v Speaker 1>switched to you now from chat, and I came up

238
00:14:46.759 --> 00:14:51.799
<v Speaker 1>with sixty five different proposed benefits of GLP one and

239
00:14:51.840 --> 00:14:57.080
<v Speaker 1>they're grouped into kind of specific organ systems. So cardiovascular

240
00:14:57.600 --> 00:15:00.000
<v Speaker 1>benefits are pretty well done.

241
00:15:00.080 --> 00:15:02.080
<v Speaker 2>So we already yeah, we already touched on.

242
00:15:02.080 --> 00:15:05.279
<v Speaker 1>That, and that's that's even down to like reduced hospitalization

243
00:15:05.440 --> 00:15:10.759
<v Speaker 1>visits associated reduced hypertension, and then metabolic benefits, which are

244
00:15:11.200 --> 00:15:13.399
<v Speaker 1>global and these are going to be related to weight

245
00:15:13.480 --> 00:15:17.600
<v Speaker 1>loss and sugar insulin diabetes, and when you start affecting

246
00:15:17.799 --> 00:15:21.919
<v Speaker 1>in a beneficial manner, that whole pathway, it pretty much

247
00:15:21.960 --> 00:15:27.200
<v Speaker 1>relates to everything else. It relates to sex, drive, to joints, exercise,

248
00:15:28.360 --> 00:15:32.679
<v Speaker 1>just pretty much whole morbidity, which is your overall disease.

249
00:15:34.279 --> 00:15:39.240
<v Speaker 1>Accumulation is improved. Hepatic disease. So you mentioned fatty liver disease,

250
00:15:39.440 --> 00:15:42.360
<v Speaker 1>but actually liver enzymes will go down, so if you

251
00:15:42.399 --> 00:15:46.000
<v Speaker 1>have any kind of associated with liver issues.

252
00:15:45.799 --> 00:15:48.759
<v Speaker 2>And the day Lily is strong on that in that

253
00:15:49.000 --> 00:15:53.960
<v Speaker 2>the indication for these drugs is there for fatty liver disease.

254
00:15:54.159 --> 00:15:57.759
<v Speaker 2>You skipped over the whole renal I'm.

255
00:15:57.600 --> 00:16:00.559
<v Speaker 1>Getting there, okay, yeah, okay, So and we'll come back

256
00:16:00.559 --> 00:16:03.799
<v Speaker 1>to renal disease. So you know, kidneys, Like, who would

257
00:16:03.799 --> 00:16:06.519
<v Speaker 1>think that kidneys are I wouldn't think that kidneys are

258
00:16:06.559 --> 00:16:10.039
<v Speaker 1>associated with like weight loss drug But so how are

259
00:16:10.080 --> 00:16:10.919
<v Speaker 1>kidneys benefited?

260
00:16:11.120 --> 00:16:14.440
<v Speaker 2>Yeah, so GLP one a's decreased micro albumin area or

261
00:16:14.519 --> 00:16:19.320
<v Speaker 2>albuminary and slow EGFR decline. There's a particular study called

262
00:16:19.320 --> 00:16:22.759
<v Speaker 2>the Flow trial which looked at semaglue tide and it

263
00:16:22.840 --> 00:16:26.679
<v Speaker 2>showed there was a twenty four percent reduction in kidney

264
00:16:26.720 --> 00:16:30.480
<v Speaker 2>outcomes such as EGF to our decline, kidney failure, and

265
00:16:30.639 --> 00:16:35.080
<v Speaker 2>kidney slash cardiovascular death. So pretty four percent.

266
00:16:35.360 --> 00:16:38.519
<v Speaker 1>So he said a lot of that's really he works there. Yeah,

267
00:16:38.519 --> 00:16:41.679
<v Speaker 1>anything about ten percent is impressive. So what he's basically

268
00:16:41.720 --> 00:16:44.960
<v Speaker 1>talking about is how well the kidney processes fluids and

269
00:16:45.080 --> 00:16:51.679
<v Speaker 1>toxins and GFR is glomyl glomerular filtration rates, and that's

270
00:16:51.759 --> 00:16:53.919
<v Speaker 1>kind of what the kidney does, It filters out.

271
00:16:54.320 --> 00:16:56.159
<v Speaker 2>And there was a meta analysis, by the way of

272
00:16:56.200 --> 00:16:59.399
<v Speaker 2>all of that data, which is a huge It still

273
00:17:00.279 --> 00:17:04.720
<v Speaker 2>seventeen percent reduction and composite kidney outcomes across the class.

274
00:17:04.839 --> 00:17:07.359
<v Speaker 2>So that's a fairly impressive.

275
00:17:07.039 --> 00:17:10.160
<v Speaker 1>And who would have thought kidneys so neurologic disorder, so

276
00:17:10.680 --> 00:17:13.720
<v Speaker 1>alcoholism and liver disease. That kind of makes sense that

277
00:17:13.759 --> 00:17:17.000
<v Speaker 1>if you're improving liver function, that doesn't mean We were

278
00:17:17.000 --> 00:17:19.400
<v Speaker 1>talking with our friends last night who are into all

279
00:17:19.440 --> 00:17:22.920
<v Speaker 1>of these vitamin supplements to improve their health, and I

280
00:17:23.000 --> 00:17:25.200
<v Speaker 1>pointed out that the biggest improvement would be to stop

281
00:17:25.279 --> 00:17:27.440
<v Speaker 1>drinking alcohol, which is a neurotoxin.

282
00:17:27.680 --> 00:17:30.079
<v Speaker 2>YEA, So I will point out to our audience that

283
00:17:30.200 --> 00:17:34.599
<v Speaker 2>they're yes in the subgroup analysis there, which means not

284
00:17:35.519 --> 00:17:38.319
<v Speaker 2>the primary outcome for the trial, but they broke down

285
00:17:38.359 --> 00:17:41.279
<v Speaker 2>the subgroups and they looked at people's alcohol intake, and

286
00:17:41.720 --> 00:17:46.160
<v Speaker 2>early signals were found for reducing alcohol and substance use,

287
00:17:46.200 --> 00:17:50.440
<v Speaker 2>although this is not totally clear and needs further investigation.

288
00:17:50.640 --> 00:17:52.960
<v Speaker 1>So I was talking about liver health and the effect

289
00:17:53.000 --> 00:17:56.559
<v Speaker 1>of the toxic alcohol, and we're recording this as we're

290
00:17:56.599 --> 00:17:58.599
<v Speaker 1>having a glass of wine, so we definitely are not

291
00:17:58.839 --> 00:18:02.799
<v Speaker 1>anti alcohol, but so the liver health benefits. But you're

292
00:18:02.799 --> 00:18:05.960
<v Speaker 1>actually talking about behavior and addiction. So the amount of

293
00:18:06.000 --> 00:18:09.559
<v Speaker 1>alcohol consumed, and this also happens with weight, that the

294
00:18:10.039 --> 00:18:15.640
<v Speaker 1>food drive, the annoying, obsessive, compulsive food thoughts get reduced,

295
00:18:15.640 --> 00:18:17.480
<v Speaker 1>and this is a huge impact on addiction.

296
00:18:17.640 --> 00:18:21.359
<v Speaker 2>Yeah, the central nervous system effects are not clearly understood

297
00:18:21.480 --> 00:18:23.720
<v Speaker 2>yet and so certainly need further investigation.

298
00:18:23.880 --> 00:18:28.960
<v Speaker 1>Yeah, but the benefits for addictive behaviors, even shopping addiction,

299
00:18:29.200 --> 00:18:33.279
<v Speaker 1>porn addiction, There are all of these sort of hints

300
00:18:33.319 --> 00:18:35.119
<v Speaker 1>that these drugs may be beneficial.

301
00:18:35.240 --> 00:18:37.920
<v Speaker 2>So again in the subgroups where we looked at trends

302
00:18:37.960 --> 00:18:41.200
<v Speaker 2>on the forest plots, we saw that the data trended

303
00:18:41.240 --> 00:18:44.640
<v Speaker 2>toward the SGLT two our GLP one.

304
00:18:44.519 --> 00:18:48.559
<v Speaker 3>A yeah crazy, so okay, And what about Alzheimer's.

305
00:18:48.720 --> 00:18:54.279
<v Speaker 2>So neuro degenerative disease. The preliminary evidence suggests some potential

306
00:18:54.319 --> 00:19:00.480
<v Speaker 2>benefits in preventing dimension improving Parkinson's disease. Again, these are

307
00:19:00.559 --> 00:19:05.200
<v Speaker 2>investigational poorly understood, but when you looked at subgroups, certainly

308
00:19:05.400 --> 00:19:08.839
<v Speaker 2>there was some indication that this needed to be evaluated further.

309
00:19:09.759 --> 00:19:11.319
<v Speaker 3>Do we have a proposed mechanism?

310
00:19:11.400 --> 00:19:11.559
<v Speaker 2>Is it?

311
00:19:11.880 --> 00:19:12.200
<v Speaker 3>We don't.

312
00:19:12.839 --> 00:19:15.640
<v Speaker 2>Again, the whole central nervous system impact of this class

313
00:19:15.720 --> 00:19:16.640
<v Speaker 2>is poorly understood.

314
00:19:17.200 --> 00:19:19.079
<v Speaker 1>And this is just what blows my mind is that

315
00:19:19.319 --> 00:19:23.039
<v Speaker 1>you know, this was launched for a very narrow, limited

316
00:19:23.799 --> 00:19:27.279
<v Speaker 1>diagnosis set and just the potential impact. I mean, there

317
00:19:27.279 --> 00:19:30.759
<v Speaker 1>are even discussions if you know entire populations. If every

318
00:19:30.799 --> 00:19:34.880
<v Speaker 1>American citizen or Australian or Canadian should be put on

319
00:19:34.960 --> 00:19:39.599
<v Speaker 1>these drugs just for overall health and well being, it's

320
00:19:39.720 --> 00:19:43.559
<v Speaker 1>just amazing. So okay, respiratory impact. So you mentioned sleep apnea,

321
00:19:43.880 --> 00:19:46.279
<v Speaker 1>So how is that benefit.

322
00:19:46.039 --> 00:19:50.680
<v Speaker 2>Tears zeppetide is approved for obstructive sleep apnea? Is a

323
00:19:50.720 --> 00:19:54.039
<v Speaker 2>web bound Well we don't know. Again, so there's the

324
00:19:54.039 --> 00:19:56.839
<v Speaker 2>whole central nervous system piece that we don't understand. But

325
00:19:56.880 --> 00:20:01.160
<v Speaker 2>then there's also that with obesity comes this pickwick in physiology,

326
00:20:01.200 --> 00:20:05.000
<v Speaker 2>which is where the diaphragm so they really excurred and

327
00:20:05.079 --> 00:20:06.240
<v Speaker 2>so then it's nine.

328
00:20:06.039 --> 00:20:09.599
<v Speaker 1>Predominal fat and you just mechanically can't breathe.

329
00:20:09.920 --> 00:20:13.640
<v Speaker 2>Yeah, So it's indicated for moderate to severe abstruct restrictive

330
00:20:13.680 --> 00:20:16.400
<v Speaker 2>sleep apney and patient in adults with obesity.

331
00:20:16.680 --> 00:20:21.480
<v Speaker 1>So even going to like arthritis and knee osteoarthritis and

332
00:20:21.559 --> 00:20:25.920
<v Speaker 1>pain and cartilage degeneration. And that's probably related to weight

333
00:20:26.039 --> 00:20:29.680
<v Speaker 1>that if you lose one hundred pounds with these drugs,

334
00:20:29.720 --> 00:20:32.319
<v Speaker 1>then that's one hundred pounds less that your knees have

335
00:20:32.359 --> 00:20:32.880
<v Speaker 1>to absorb.

336
00:20:33.039 --> 00:20:36.519
<v Speaker 2>Yeah, So there is symptomatic improvement with this class in

337
00:20:37.839 --> 00:20:44.000
<v Speaker 2>knee specifically knee osteoarthritis, and we think that is probably

338
00:20:44.039 --> 00:20:49.079
<v Speaker 2>related to, you know, just the weight tension on the joint,

339
00:20:49.119 --> 00:20:50.240
<v Speaker 2>although we just don't know.

340
00:20:50.519 --> 00:20:55.599
<v Speaker 1>Okay, women's mental stricles become more stable and predictable and regulated.

341
00:20:55.640 --> 00:20:57.079
<v Speaker 3>What the hell's up with that?

342
00:20:57.119 --> 00:21:00.000
<v Speaker 1>Like, how does a weightless drug cause better menstrual suz.

343
00:21:00.000 --> 00:21:02.319
<v Speaker 2>So if you just think about it, that is where

344
00:21:02.359 --> 00:21:05.920
<v Speaker 2>hormones are stored, right, and so then you start reducing

345
00:21:06.720 --> 00:21:09.720
<v Speaker 2>fatty tissue in central obesity, and then you start shifting

346
00:21:09.759 --> 00:21:14.319
<v Speaker 2>hormones and so people do have some hormonal shift that occurs.

347
00:21:15.200 --> 00:21:17.160
<v Speaker 1>Again, this just blows my mind. This is one of

348
00:21:17.200 --> 00:21:21.640
<v Speaker 1>the most amazing things I've ever even contemplated. We talked

349
00:21:21.680 --> 00:21:26.160
<v Speaker 1>about neurodegenerative diseases like Alzheimer's.

350
00:21:26.200 --> 00:21:28.680
<v Speaker 3>What about stroke reduction? Is there any benefit for that?

351
00:21:29.599 --> 00:21:35.680
<v Speaker 2>The drugs are indicated for cardiovascular event reduction, which includes stroke,

352
00:21:36.599 --> 00:21:40.880
<v Speaker 2>so of all cardiovascular disease, so that's included there yet Okay.

353
00:21:41.039 --> 00:21:44.000
<v Speaker 1>And then I've talked about my chronic migraines. This is

354
00:21:44.440 --> 00:21:47.519
<v Speaker 1>researching this. I learned this that there's actually some evidence

355
00:21:47.599 --> 00:21:52.839
<v Speaker 1>that migraines become less severe and less episodic, so fewer

356
00:21:52.920 --> 00:21:55.599
<v Speaker 1>migraines per month on these trucks.

357
00:21:55.799 --> 00:21:59.400
<v Speaker 2>Yeah, so this is evidence coming from the subgroup analysis

358
00:21:59.480 --> 00:22:05.039
<v Speaker 2>and again poorly understood, not absolutely indicated, So make sure

359
00:22:05.039 --> 00:22:08.279
<v Speaker 2>our audience understands that, but also knowing that there is

360
00:22:08.319 --> 00:22:12.519
<v Speaker 2>some potential potential for improvement in those symptoms.

361
00:22:13.279 --> 00:22:17.119
<v Speaker 1>Just so I've rethought starting to take these. I'm not

362
00:22:17.599 --> 00:22:20.759
<v Speaker 1>terribly obese, and actually I'm very sensitive to the side effects,

363
00:22:21.279 --> 00:22:23.200
<v Speaker 1>which we're going to cover in the next section. But

364
00:22:23.599 --> 00:22:27.640
<v Speaker 1>I've actually restarted these for my migraines. I've had horribly

365
00:22:27.759 --> 00:22:34.319
<v Speaker 1>uncontrolled migraines. Okay, so then what about reproductive benefits. We

366
00:22:34.400 --> 00:22:38.079
<v Speaker 1>talked about the menstrual cycles that reproductive fertility seems to

367
00:22:38.119 --> 00:22:39.200
<v Speaker 1>be increasing in this way.

368
00:22:39.279 --> 00:22:42.440
<v Speaker 2>Yeah, so again, you know, you look at something when

369
00:22:42.519 --> 00:22:47.119
<v Speaker 2>you look at a syndrome like PCOS polycystic ovarian syndrome,

370
00:22:47.160 --> 00:22:52.359
<v Speaker 2>which can contribute to some infertility issues, and it's kind

371
00:22:52.400 --> 00:22:57.240
<v Speaker 2>of a pre diabetic state and that impacts fertility. Again,

372
00:22:57.640 --> 00:23:02.119
<v Speaker 2>fatty tissue stores hormones and shifts hormones, and so we

373
00:23:02.240 --> 00:23:06.799
<v Speaker 2>just don't really know, but there is some some data

374
00:23:06.920 --> 00:23:09.440
<v Speaker 2>and evidence in the subgroups to indicate there might be

375
00:23:09.480 --> 00:23:15.279
<v Speaker 2>some benefit there. Just mind blowing, well, I think, yeah,

376
00:23:15.519 --> 00:23:20.359
<v Speaker 2>so I think that they're at my pliants. So we

377
00:23:21.440 --> 00:23:25.720
<v Speaker 2>in the US, all food is readily available everywhere. You

378
00:23:25.799 --> 00:23:27.839
<v Speaker 2>drive down the highway and there are signs everywhere, and.

379
00:23:27.799 --> 00:23:29.519
<v Speaker 3>We eat French fries for a week more.

380
00:23:29.599 --> 00:23:31.400
<v Speaker 2>Then we go to a restaurant and we're served a

381
00:23:31.440 --> 00:23:36.920
<v Speaker 2>three person portion and we continue to eat that way

382
00:23:37.039 --> 00:23:41.680
<v Speaker 2>and our bodies can't, uh can't keep up, and so

383
00:23:41.839 --> 00:23:44.519
<v Speaker 2>then there's this shifting of hormones that all of the

384
00:23:44.519 --> 00:23:52.799
<v Speaker 2>obesity problem does impact neuroentocrine system, central nervous system, cardiovascular system.

385
00:23:53.160 --> 00:23:56.680
<v Speaker 2>And so this impact is what we're trying to understand better.

386
00:23:56.759 --> 00:23:59.920
<v Speaker 1>And then what actually stimulated us researching this and do

387
00:24:00.039 --> 00:24:03.400
<v Speaker 1>in this episode was recent information that was just released

388
00:24:03.400 --> 00:24:08.119
<v Speaker 1>on cancer rates. Yeah, so anything above ten percent is impressive,

389
00:24:08.240 --> 00:24:12.759
<v Speaker 1>and the recent data looks at reduction in cancer all

390
00:24:12.799 --> 00:24:17.599
<v Speaker 1>sorts of cancer, prostate, ovarian, breast cancer of twenty to

391
00:24:17.640 --> 00:24:18.319
<v Speaker 1>thirty percent.

392
00:24:18.440 --> 00:24:23.480
<v Speaker 2>So again, the latest information on this particular evidence is

393
00:24:23.519 --> 00:24:27.839
<v Speaker 2>that we don't really know. An Umbrella review found no

394
00:24:27.880 --> 00:24:33.240
<v Speaker 2>substantial association between GLP one ra's use and cancer risk

395
00:24:33.319 --> 00:24:41.079
<v Speaker 2>across thyroid, pancreatic, and overall cancer outcomes. So we don't know,

396
00:24:41.519 --> 00:24:44.480
<v Speaker 2>and I think it's important for people to really understand

397
00:24:44.720 --> 00:24:50.599
<v Speaker 2>that in that certainly port eating can cause all kinds

398
00:24:50.599 --> 00:24:52.000
<v Speaker 2>of GI cancers and this and that.

399
00:24:52.799 --> 00:24:55.279
<v Speaker 1>So one of the reason he mentioned thiraid is one

400
00:24:55.319 --> 00:24:58.160
<v Speaker 1>of the contraindications in the next section. We're going to

401
00:24:58.160 --> 00:25:00.559
<v Speaker 1>take a break and come back with side of But

402
00:25:00.640 --> 00:25:03.559
<v Speaker 1>one of the contraindications of this drug was a genetic

403
00:25:03.680 --> 00:25:07.559
<v Speaker 1>tendency towards thyroid cancer, and so they were specifically looking

404
00:25:07.599 --> 00:25:10.359
<v Speaker 1>at does this drug really cause an increase in thyroid

405
00:25:10.400 --> 00:25:14.440
<v Speaker 1>cancer with people with this genetic trait, And it turns

406
00:25:14.480 --> 00:25:18.319
<v Speaker 1>out that a huge meta analysis of ninety different studies

407
00:25:18.319 --> 00:25:22.319
<v Speaker 1>that there's no correlation. So that's not specifically talking to

408
00:25:22.359 --> 00:25:25.480
<v Speaker 1>the reduction in breast cancer. That's just talking about one

409
00:25:25.480 --> 00:25:28.160
<v Speaker 1>of the potential side effects. So we're going to take

410
00:25:28.160 --> 00:25:29.559
<v Speaker 1>a break here and then we're going to talk about

411
00:25:29.559 --> 00:25:33.319
<v Speaker 1>the side effects when we come back. Sound good, Okay,

412
00:25:33.440 --> 00:25:36.559
<v Speaker 1>we'll be right back. Hang with us again. Mind blowing

413
00:25:37.319 --> 00:25:41.759
<v Speaker 1>crazy therapy, Alice in Wonderland, magic medicine kind of stuff.

414
00:25:41.920 --> 00:25:54.839
<v Speaker 1>We'll be right back. Okay, we're back. I hope you

415
00:25:54.960 --> 00:25:58.079
<v Speaker 1>stayed with us. So now we're kind of in the

416
00:25:58.119 --> 00:26:00.960
<v Speaker 1>side effect the benefits of all of these things are

417
00:26:01.000 --> 00:26:05.160
<v Speaker 1>expanding and in ways that are again mind blowing for me.

418
00:26:06.119 --> 00:26:10.440
<v Speaker 1>But so the two big really scary things three probably

419
00:26:10.519 --> 00:26:14.079
<v Speaker 1>that were associated with these therapies was the genetic risk

420
00:26:14.160 --> 00:26:16.880
<v Speaker 1>of thyroid cancer, and you just mentioned that, studies now

421
00:26:16.960 --> 00:26:20.559
<v Speaker 1>show that's probably not as significant as what it was

422
00:26:20.599 --> 00:26:21.400
<v Speaker 1>initially thought.

423
00:26:21.519 --> 00:26:21.759
<v Speaker 3>That is.

424
00:26:22.319 --> 00:26:26.279
<v Speaker 1>The other big issue was retinal blindness associated with our

425
00:26:27.240 --> 00:26:33.400
<v Speaker 1>arteritis so vessels in the retina, and huge large meta

426
00:26:33.440 --> 00:26:36.720
<v Speaker 1>analysis multiple studies show that the risk of blindness with

427
00:26:36.799 --> 00:26:39.200
<v Speaker 1>these drugs is also pretty negligible.

428
00:26:39.319 --> 00:26:42.079
<v Speaker 2>So I think it's important also to point out that

429
00:26:41.519 --> 00:26:45.519
<v Speaker 2>that very same meta analysis that was done showed there

430
00:26:45.599 --> 00:26:49.799
<v Speaker 2>was no significant increase for hypoglycemia. So people get all

431
00:26:49.839 --> 00:26:52.599
<v Speaker 2>caught up because they're on all these things, and so

432
00:26:52.640 --> 00:26:55.839
<v Speaker 2>they're concerned about their blood sugar dropping. And certainly if

433
00:26:55.839 --> 00:26:56.759
<v Speaker 2>you can.

434
00:26:56.680 --> 00:26:59.799
<v Speaker 3>Cause you to feint to pass out, have car accidents.

435
00:26:59.319 --> 00:27:04.920
<v Speaker 2>If you are on insulin or diabetic agents, certainly at warrants,

436
00:27:05.039 --> 00:27:08.759
<v Speaker 2>as you lose weight, that your requirement for insulin will

437
00:27:08.759 --> 00:27:12.519
<v Speaker 2>go down, or your requirement for those medications may go down.

438
00:27:12.559 --> 00:27:15.920
<v Speaker 2>So it's really important to keep monitoring and discuss that

439
00:27:15.960 --> 00:27:17.119
<v Speaker 2>with your provider if.

440
00:27:17.000 --> 00:27:22.640
<v Speaker 1>You're disabetic doing these drugs, you absolutely need very frequent monitoring.

441
00:27:22.119 --> 00:27:26.160
<v Speaker 3>By your provider. Also, that's exactly what these drugs affect.

442
00:27:26.319 --> 00:27:29.799
<v Speaker 2>That meta analysis also did not show an increase in

443
00:27:29.839 --> 00:27:33.160
<v Speaker 2>the risk of retinopay or pancreatic events, and so that

444
00:27:33.960 --> 00:27:38.839
<v Speaker 2>really was reassuring to the population that those were not

445
00:27:39.039 --> 00:27:42.839
<v Speaker 2>going to be issues unless you had a previous history

446
00:27:43.079 --> 00:27:45.160
<v Speaker 2>of some pancreatic you know, right.

447
00:27:45.279 --> 00:27:51.319
<v Speaker 1>So, pancreatitis is the pancreas produces digestive enzymes that get

448
00:27:51.359 --> 00:27:54.319
<v Speaker 1>released in the small intestine and they help break down

449
00:27:54.359 --> 00:27:59.279
<v Speaker 1>proteins and carbohydrates and absorb various nutrients. So when you

450
00:27:59.359 --> 00:28:02.559
<v Speaker 1>have like a really really bad faty meal, or if

451
00:28:02.559 --> 00:28:07.119
<v Speaker 1>you're predisposed and you have leaking of these gastric pancreatic enzymes,

452
00:28:07.400 --> 00:28:10.480
<v Speaker 1>you get a parrotinitis and really severe pain, and it

453
00:28:10.519 --> 00:28:13.960
<v Speaker 1>can be life threatening. So that was one of the

454
00:28:14.079 --> 00:28:17.920
<v Speaker 1>potential side effects, and I will say that that is

455
00:28:17.960 --> 00:28:20.880
<v Speaker 1>still probably the group of side effects that are most prominent.

456
00:28:20.960 --> 00:28:25.720
<v Speaker 2>Well, the most prominent are nausea, vomiting, and diarrhea.

457
00:28:25.079 --> 00:28:27.839
<v Speaker 1>Which I'm very very sensitive to these drugs. I've been

458
00:28:27.960 --> 00:28:30.799
<v Speaker 1>I tried to go on various different ones over the

459
00:28:30.839 --> 00:28:33.279
<v Speaker 1>course of a couple of years, and I'm trying them

460
00:28:33.279 --> 00:28:36.759
<v Speaker 1>again for my migraines, but I am extremely sensitive to

461
00:28:36.799 --> 00:28:42.599
<v Speaker 1>the nausea aspect. My daughter, genetically related to me, actually

462
00:28:42.599 --> 00:28:44.799
<v Speaker 1>tried these drugs. She was probably one hundred and fifty

463
00:28:44.799 --> 00:28:48.200
<v Speaker 1>pounds overweight, ended up in the hospital with chronic vomiting

464
00:28:48.240 --> 00:28:52.160
<v Speaker 1>for three days that she couldn't control. And those side

465
00:28:52.200 --> 00:28:54.920
<v Speaker 1>effects are the most common and they can definitely be

466
00:28:56.799 --> 00:28:58.440
<v Speaker 1>diminished by dose.

467
00:28:58.279 --> 00:29:03.240
<v Speaker 2>Regulation, so you can mitigate most of the nausea, vomiting,

468
00:29:03.279 --> 00:29:08.559
<v Speaker 2>and diarrhea. BA gradual dose titration is very effectively kind

469
00:29:08.559 --> 00:29:11.599
<v Speaker 2>of you know, microdose at the front end and work

470
00:29:11.640 --> 00:29:14.200
<v Speaker 2>your way up, which is what is recommended and certainly

471
00:29:14.240 --> 00:29:17.559
<v Speaker 2>within the labeling of these drugs. And then as we

472
00:29:17.599 --> 00:29:23.279
<v Speaker 2>move forward, some of the emerging concerns, which we will

473
00:29:23.319 --> 00:29:26.160
<v Speaker 2>dive into a bit is potential loss of muscle and

474
00:29:26.200 --> 00:29:28.240
<v Speaker 2>bone mass with weight loss.

475
00:29:28.319 --> 00:29:31.319
<v Speaker 1>Yeah, so this is the ozimpic face, is what it's

476
00:29:31.359 --> 00:29:36.039
<v Speaker 1>been called on Doctor TikTok, where you lose fat and

477
00:29:36.640 --> 00:29:39.400
<v Speaker 1>some muscle, but mainly the fat in the muscle, and

478
00:29:39.440 --> 00:29:42.119
<v Speaker 1>then you start looking kind of skeletal, and a lot

479
00:29:42.200 --> 00:29:45.759
<v Speaker 1>of celebrities we're just talking to our other daughter on

480
00:29:45.920 --> 00:29:49.519
<v Speaker 1>this is Father's Day when we're recording this, and we're

481
00:29:49.519 --> 00:29:53.119
<v Speaker 1>showing pictures of celebrities that look pretty skeletal.

482
00:29:53.319 --> 00:29:55.200
<v Speaker 3>Yeah, and that's definitely one of the side effects.

483
00:29:55.240 --> 00:29:58.119
<v Speaker 1>So how does that happen, Like, what's the mechanism of

484
00:29:58.240 --> 00:29:59.559
<v Speaker 1>that skeletal appearance.

485
00:29:59.640 --> 00:30:03.640
<v Speaker 2>Well, so there's some concern of true muscle loss. But

486
00:30:03.720 --> 00:30:05.079
<v Speaker 2>then also, and.

487
00:30:05.039 --> 00:30:08.359
<v Speaker 1>We talked previously that muscle mass is a huge metabolic

488
00:30:08.519 --> 00:30:11.079
<v Speaker 1>organ and if you're losing muscle mass, all sorts of

489
00:30:11.319 --> 00:30:12.319
<v Speaker 1>bad things can happen.

490
00:30:12.359 --> 00:30:13.279
<v Speaker 3>So we like muscle.

491
00:30:13.440 --> 00:30:17.359
<v Speaker 2>So there's muscle tissue, skeletal muscle tissue, but then there's

492
00:30:17.400 --> 00:30:23.200
<v Speaker 2>also the fat. As we get fatter, deposits into muscle

493
00:30:23.240 --> 00:30:27.880
<v Speaker 2>tissue and so then the muscle gets more lean. Additionally,

494
00:30:28.000 --> 00:30:31.640
<v Speaker 2>then you've got the loss of subcutaneous tissue and so fat.

495
00:30:31.759 --> 00:30:34.559
<v Speaker 1>Yeah, most of your dormis or that if you can

496
00:30:34.880 --> 00:30:37.680
<v Speaker 1>pinch your skin, most of what you're pinching is actually fat.

497
00:30:37.799 --> 00:30:41.359
<v Speaker 2>And there are ongoing studies looking at that particular issue.

498
00:30:41.440 --> 00:30:43.640
<v Speaker 2>So I think we just need to make sure that

499
00:30:43.920 --> 00:30:49.079
<v Speaker 2>we know that you know, when we're losing weight, we

500
00:30:49.160 --> 00:30:52.240
<v Speaker 2>want to achieve healthy weight loss. We want to make

501
00:30:52.240 --> 00:30:57.480
<v Speaker 2>sure we keep our protein intake high while we're losing weight.

502
00:30:57.640 --> 00:31:00.200
<v Speaker 1>So then one of our friends the other night brought

503
00:31:00.279 --> 00:31:04.440
<v Speaker 1>up could you take other peptides like a growth hormone

504
00:31:05.000 --> 00:31:09.640
<v Speaker 1>analog to then stimulate muscle development, And we talked about

505
00:31:09.680 --> 00:31:12.640
<v Speaker 1>all of these peptides having benefits and side effects, and

506
00:31:12.680 --> 00:31:15.920
<v Speaker 1>the problem with growth hormone therapy is that it can

507
00:31:15.960 --> 00:31:19.480
<v Speaker 1>cause diabetes. So you know, you want to be careful

508
00:31:19.519 --> 00:31:22.359
<v Speaker 1>what you're mixing and matching here that if you're having

509
00:31:22.359 --> 00:31:25.440
<v Speaker 1>a side effect of muscle loss, you know, don't necessarily

510
00:31:25.480 --> 00:31:28.799
<v Speaker 1>rely on another treatment quick and easy fix, because that

511
00:31:28.799 --> 00:31:33.559
<v Speaker 1>can have side effects too. So interesting, before we get

512
00:31:33.599 --> 00:31:36.559
<v Speaker 1>into weird things, any other kind of documented side effects

513
00:31:36.559 --> 00:31:37.440
<v Speaker 1>that you'd like to talk about?

514
00:31:37.720 --> 00:31:39.599
<v Speaker 2>Those are the big ones. I did have a question

515
00:31:39.680 --> 00:31:42.720
<v Speaker 2>for you, Keith in that in the bitinery medicine world,

516
00:31:42.799 --> 00:31:47.039
<v Speaker 2>what is the space looking like for animal health and

517
00:31:48.160 --> 00:31:51.400
<v Speaker 2>are we using GLP one ris for animals and are

518
00:31:51.440 --> 00:31:54.839
<v Speaker 2>they documenting the same side effects that we're having and

519
00:31:55.279 --> 00:31:57.480
<v Speaker 2>clearly some are not documentable.

520
00:31:57.640 --> 00:32:00.480
<v Speaker 1>But yeah, so let me answer that in a second

521
00:32:00.519 --> 00:32:02.480
<v Speaker 1>after I talk about the other kind of weird human

522
00:32:02.559 --> 00:32:03.160
<v Speaker 1>side effects.

523
00:32:03.920 --> 00:32:06.240
<v Speaker 3>The other weird thing that's.

524
00:32:06.039 --> 00:32:09.160
<v Speaker 1>Happening with these drugs and side effects that we really

525
00:32:09.279 --> 00:32:13.279
<v Speaker 1>don't quite know and understand relates to the gastric motility.

526
00:32:13.359 --> 00:32:17.799
<v Speaker 1>So all of these drugs, you know, affect gastric motility, appetite,

527
00:32:17.839 --> 00:32:22.240
<v Speaker 1>eating calories in bulk fiber. Just you're eating less, you're

528
00:32:22.240 --> 00:32:25.880
<v Speaker 1>pooping less, your gi system slows down, and what that

529
00:32:26.039 --> 00:32:30.279
<v Speaker 1>seems to be doing is decreasing the absorption of some drugs.

530
00:32:30.400 --> 00:32:34.240
<v Speaker 2>Yeah, so he's speaking to gastroparesis, which is one of

531
00:32:34.279 --> 00:32:38.680
<v Speaker 2>the potential side effects flowing down of the gut. And

532
00:32:39.400 --> 00:32:42.119
<v Speaker 2>certainly when the gut slows down and you take other

533
00:32:42.160 --> 00:32:47.440
<v Speaker 2>medications and then the transit time for those medications in

534
00:32:47.559 --> 00:32:53.400
<v Speaker 2>the gut is decreased and so absorption is higher.

535
00:32:52.759 --> 00:32:54.039
<v Speaker 3>Usually lowers the concern.

536
00:32:54.359 --> 00:32:57.759
<v Speaker 1>So the problem with this, and it could be higher too,

537
00:32:57.799 --> 00:33:00.440
<v Speaker 1>But the problem is that if you're on certain drugs

538
00:33:00.440 --> 00:33:03.880
<v Speaker 1>that are really really important, like statins for your cholesterol,

539
00:33:03.920 --> 00:33:07.839
<v Speaker 1>and suddenly your drug dose goes down or up, that's

540
00:33:07.839 --> 00:33:10.680
<v Speaker 1>a problem. Birth control. If you're taking birth control and

541
00:33:10.759 --> 00:33:14.039
<v Speaker 1>it becomes less effective, less absorbed, and you get pregnant,

542
00:33:14.160 --> 00:33:15.440
<v Speaker 1>that's a pretty big side effect.

543
00:33:15.480 --> 00:33:17.559
<v Speaker 2>So the point that I was making with the higher

544
00:33:17.640 --> 00:33:21.519
<v Speaker 2>absorption drug is that the pharmacode dynamics have now changed

545
00:33:22.119 --> 00:33:23.119
<v Speaker 2>and we don't.

546
00:33:22.880 --> 00:33:25.039
<v Speaker 3>Know yet, so you have to be careful though. Yeah.

547
00:33:25.759 --> 00:33:28.720
<v Speaker 2>Yeah, so I think more information needs to come forth about,

548
00:33:29.160 --> 00:33:33.559
<v Speaker 2>you know, dosing with other medications on board. However, if

549
00:33:33.559 --> 00:33:36.599
<v Speaker 2>antibotics for NOMEN in their studies, you know, the drug

550
00:33:36.680 --> 00:33:39.880
<v Speaker 2>drug interactions are not super impressive.

551
00:33:39.960 --> 00:33:41.640
<v Speaker 3>So yeah, but it's a concern.

552
00:33:41.680 --> 00:33:43.960
<v Speaker 1>I mean, certainly if one of the side effects is

553
00:33:43.960 --> 00:33:46.160
<v Speaker 1>getting pregnant, that you know, we need to kind of

554
00:33:46.200 --> 00:33:48.839
<v Speaker 1>know about that. The other thing that we really don't

555
00:33:48.880 --> 00:33:51.559
<v Speaker 1>know is what's going to happen in thirty years when

556
00:33:51.599 --> 00:33:54.640
<v Speaker 1>you stop these drugs the weight gain returns?

557
00:33:54.720 --> 00:33:55.279
<v Speaker 3>Is that correct?

558
00:33:55.480 --> 00:34:00.720
<v Speaker 2>It does? And so the point being that if certainly

559
00:34:00.960 --> 00:34:04.920
<v Speaker 2>for the indicated use, what we don't know and what

560
00:34:04.960 --> 00:34:08.239
<v Speaker 2>we hope to have more information on is maintenance dose.

561
00:34:08.440 --> 00:34:10.480
<v Speaker 2>Is there a maintenance dose or do we stop?

562
00:34:10.639 --> 00:34:11.800
<v Speaker 3>Yeah, could you use this?

563
00:34:11.920 --> 00:34:14.440
<v Speaker 2>So we just don't know that we don't have or

564
00:34:14.440 --> 00:34:14.719
<v Speaker 2>take it.

565
00:34:14.719 --> 00:34:16.519
<v Speaker 3>We don't have once a year, or we.

566
00:34:16.480 --> 00:34:19.960
<v Speaker 2>Don't have you know, twenty year studies to look at

567
00:34:20.079 --> 00:34:24.719
<v Speaker 2>outcomes that far out. And so these are question unanswered

568
00:34:24.800 --> 00:34:26.079
<v Speaker 2>questions on the human side.

569
00:34:26.199 --> 00:34:28.760
<v Speaker 1>Yeah, So going back to veterinary medicine. We're talking with

570
00:34:28.800 --> 00:34:32.440
<v Speaker 1>some friends about this last night, and there are a

571
00:34:32.480 --> 00:34:35.679
<v Speaker 1>lot of medications that on the veterinary side we can

572
00:34:35.840 --> 00:34:38.199
<v Speaker 1>use them because they have a lot of side effects.

573
00:34:38.239 --> 00:34:41.760
<v Speaker 1>But the dogs only live fifteen years, where humans live

574
00:34:41.840 --> 00:34:44.960
<v Speaker 1>potentially ninety years, and so if you're on a drug

575
00:34:45.000 --> 00:34:47.119
<v Speaker 1>for thirty years, that's a lot different than being on

576
00:34:47.159 --> 00:34:50.679
<v Speaker 1>a medication for three years. So there is a there

577
00:34:50.760 --> 00:34:53.800
<v Speaker 1>is an absolute difference in a lot of medications in

578
00:34:53.840 --> 00:34:56.719
<v Speaker 1>the veterinary world that we can use and avoid the

579
00:34:56.719 --> 00:35:00.320
<v Speaker 1>side effects simply because the lifespan is much short. And

580
00:35:00.320 --> 00:35:03.280
<v Speaker 1>that's sad, but that's just the reality. The other question

581
00:35:03.480 --> 00:35:05.719
<v Speaker 1>that you had asked before is are we using these

582
00:35:05.800 --> 00:35:08.679
<v Speaker 1>drugs in veterinary medicine, And the answer is that we're

583
00:35:08.840 --> 00:35:12.519
<v Speaker 1>beginning to. They're very expensive, and so a cost price

584
00:35:12.920 --> 00:35:14.320
<v Speaker 1>threshold is a little bit of.

585
00:35:14.239 --> 00:35:17.800
<v Speaker 2>A So are there any studies among dogs or cats?

586
00:35:17.960 --> 00:35:21.480
<v Speaker 1>Is actually where most of the interesting information is. So

587
00:35:21.599 --> 00:35:25.360
<v Speaker 1>most indoor cats are obese as they get older. And

588
00:35:25.400 --> 00:35:27.880
<v Speaker 1>what's also interesting is that they have a lot of

589
00:35:28.760 --> 00:35:35.039
<v Speaker 1>very annoying OCD food seeking behavior tendencies that drive you

590
00:35:35.039 --> 00:35:37.760
<v Speaker 1>own are crazy. So my daughter's cat when we go

591
00:35:37.840 --> 00:35:42.880
<v Speaker 1>visit non stop, is begging, meowing, buying at your ankles,

592
00:35:42.920 --> 00:35:47.679
<v Speaker 1>wanting food and very healthy weight cat but just once food,

593
00:35:47.719 --> 00:35:49.719
<v Speaker 1>NonStop and if you give it food, then it vomits

594
00:35:49.719 --> 00:35:52.639
<v Speaker 1>because it ate too much food. So these drugs, actually

595
00:35:52.800 --> 00:35:55.679
<v Speaker 1>they're not big studies. So we have like six animals here,

596
00:35:55.719 --> 00:35:59.400
<v Speaker 1>ten animals here, very very small compared to the human side,

597
00:35:59.519 --> 00:36:04.199
<v Speaker 1>but they are showing benefit in obesity and diabetes is

598
00:36:04.239 --> 00:36:06.719
<v Speaker 1>not that common in dogs, much more common in cats,

599
00:36:07.079 --> 00:36:11.639
<v Speaker 1>and so definitely this is something that's being explored across species,

600
00:36:12.119 --> 00:36:14.639
<v Speaker 1>and you know, it seems to have a lot of benefit.

601
00:36:14.920 --> 00:36:21.159
<v Speaker 1>But again mind blowing crazy, you know, unpredictable. Human medicine

602
00:36:21.239 --> 00:36:26.000
<v Speaker 1>had no glimpse of where this drug was headed in the.

603
00:36:25.960 --> 00:36:29.800
<v Speaker 2>Potential, so in animal size, it looks like exanatide is

604
00:36:29.840 --> 00:36:31.159
<v Speaker 2>the drug that's being used.

605
00:36:31.199 --> 00:36:32.440
<v Speaker 3>I was just looking at me.

606
00:36:32.679 --> 00:36:34.840
<v Speaker 1>We use a lot of compounded drugs, so the Supreme

607
00:36:34.880 --> 00:36:38.960
<v Speaker 1>Court said that you can't patent these or trademark copyright

608
00:36:39.000 --> 00:36:42.000
<v Speaker 1>these drugs, and so there are a lot of compounded

609
00:36:42.880 --> 00:36:46.880
<v Speaker 1>drugs available. If we're using brand names, it gets really expensive.

610
00:36:46.960 --> 00:36:52.000
<v Speaker 2>It appears in cats there was a forty percent diabetic

611
00:36:52.119 --> 00:36:56.639
<v Speaker 2>remission versus twenty percent in control, so kind of again about.

612
00:36:56.360 --> 00:36:59.119
<v Speaker 1>Ten percent how many cats though, so it was it

613
00:36:59.159 --> 00:37:00.000
<v Speaker 1>was a small stuff.

614
00:37:00.119 --> 00:37:01.000
<v Speaker 3>Yeah, and that's the problem.

615
00:37:01.039 --> 00:37:04.360
<v Speaker 2>So the confidence intervals are really wide and so trusting

616
00:37:04.480 --> 00:37:05.440
<v Speaker 2>that data is.

617
00:37:05.880 --> 00:37:08.000
<v Speaker 3>Based on the human data. I mean, it definitely looks

618
00:37:08.000 --> 00:37:09.360
<v Speaker 3>like it has a lot of potential.

619
00:37:09.039 --> 00:37:11.719
<v Speaker 2>Sport to five cats by the way, five cats, Yeah,

620
00:37:11.719 --> 00:37:16.280
<v Speaker 2>that's not really a well that's medic caase study case report.

621
00:37:16.440 --> 00:37:20.559
<v Speaker 1>Okay, So that's our update on the GLP ones. Please

622
00:37:20.639 --> 00:37:23.719
<v Speaker 1>send us any questions or comments to ask at itch

623
00:37:24.000 --> 00:37:27.960
<v Speaker 1>dot com. As always, visit our sponsors. Our primary sponsor

624
00:37:28.039 --> 00:37:32.280
<v Speaker 1>is dot itchy dot com medical Pets supplements for your

625
00:37:32.360 --> 00:37:37.840
<v Speaker 1>dogs and cats, and visit our websites at itchy and

626
00:37:38.000 --> 00:37:39.760
<v Speaker 1>bitchy dot com or.

627
00:37:40.119 --> 00:37:44.440
<v Speaker 2>Our Facebook page which is I n B Podcast And

628
00:37:44.599 --> 00:37:49.239
<v Speaker 2>so like the page and then rate us. We invite

629
00:37:49.280 --> 00:37:51.519
<v Speaker 2>you to rate us and follow us. We really want

630
00:37:51.519 --> 00:37:54.320
<v Speaker 2>your feedback and we're so thrilled that you've chosen your

631
00:37:54.320 --> 00:37:56.480
<v Speaker 2>week to join us.

632
00:37:56.880 --> 00:38:01.079
<v Speaker 3>Stay well, stay safe, get up and move Okay, Bye

633
00:38:01.079 --> 00:38:01.599
<v Speaker 3>bye guys,
